Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The potential of individualized dosing of ravulizumab to improve patient-friendliness of paroxysmal nocturnal haemoglobinuria treatment at reduced costs.
Ter Avest M, Langemeijer SMC, Schols SEM, Burger DM, van de Kar NCAJ, Blijlevens NMA, Kievit W, Ter Heine R. Ter Avest M, et al. Among authors: blijlevens nma. Br J Clin Pharmacol. 2021 Aug;87(8):3359-3363. doi: 10.1111/bcp.14748. Epub 2021 Feb 23. Br J Clin Pharmacol. 2021. PMID: 33512711 Free PMC article.
Von Willebrand disease type 2M: Correlation between genotype and phenotype.
Maas DPMSM, Atiq F, Blijlevens NMA, Brons PPT, Krouwel S, Laros-van Gorkom BAP, Leebeek FWG, Nieuwenhuizen L, Schoormans SCM, Simons A, Meijer D, van Heerde WL, Schols SEM. Maas DPMSM, et al. Among authors: blijlevens nma. J Thromb Haemost. 2022 Feb;20(2):316-327. doi: 10.1111/jth.15586. Epub 2021 Nov 21. J Thromb Haemost. 2022. PMID: 34758185 Free PMC article.
Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A.
Bukkems LH, Valke LLFG, Barteling W, Laros-van Gorkom BAP, Blijlevens NMA, Cnossen MH, van Heerde WL, Schols SEM, Mathôt RAA. Bukkems LH, et al. Among authors: blijlevens nma. Br J Clin Pharmacol. 2022 Jun;88(6):2757-2768. doi: 10.1111/bcp.15185. Epub 2022 Jan 15. Br J Clin Pharmacol. 2022. PMID: 34921439 Free PMC article.
Treatment of patients with rare bleeding disorders in the Netherlands: Real-life data from the RBiN study.
Maas DPMSM, Saes JL, Blijlevens NMA, Cnossen MH, den Exter PL, Kruis IC, Meijer K, Nieuwenhuizen L, Peters M, Schutgens REG, van Heerde WL, Schols SEM; RBiN study group. Maas DPMSM, et al. Among authors: blijlevens nma. J Thromb Haemost. 2022 Apr;20(4):833-844. doi: 10.1111/jth.15652. Epub 2022 Feb 8. J Thromb Haemost. 2022. PMID: 35038781 Free PMC article.
Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield.
Valke LLFG, Meijer D, Nieuwenhuizen L, Laros-van Gorkom BAP, Blijlevens NMA, van Heerde WL, Schols SEM. Valke LLFG, et al. Among authors: blijlevens nma. Res Pract Thromb Haemost. 2022 Mar 15;6(2):e12681. doi: 10.1002/rth2.12681. eCollection 2022 Feb. Res Pract Thromb Haemost. 2022. PMID: 35316940 Free PMC article.
High prevalence of postpartum hemorrhage in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study.
Maas DPMSM, Saes JL, Blijlevens NMA, Cnossen MH, den Exter PL, van der Heijden OWH, Kruis IC, Meijer K, Peters M, Schutgens REG, van Heerde WL, Nieuwenhuizen L, Schols SEM; RBiN study group. Maas DPMSM, et al. Among authors: blijlevens nma. J Thromb Haemost. 2023 Mar;21(3):499-512. doi: 10.1016/j.jtha.2022.11.009. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696205 Free article.
285 results